Cargando…
How Can Dupilumab Cause Eosinophilic Pneumonia?
Reports of eosinophilic pneumonia (EP) as a side effect of dupilumab administration are limited in previous studies. Herein, we report two cases in which EP developed subsequent to the administration of dupilumab for eosinophilic chronic rhinosinusitis (ECRS). Case 1: A 55-year-old woman presented w...
Autores principales: | Kurihara, Momoko, Masaki, Katsunori, Matsuyama, Emiko, Fujioka, Masato, Hayashi, Reina, Tomiyasu, Saki, Sasahara, Kotaro, Sunata, Keeya, Asaoka, Masato, Akiyama, Yuto, Nishie, Miyuki, Irie, Misato, Tanosaki, Takae, Kabata, Hiroki, Fukunaga, Koichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9775034/ https://www.ncbi.nlm.nih.gov/pubmed/36551171 http://dx.doi.org/10.3390/biom12121743 |
Ejemplares similares
-
Heterogeneity of ILC2s in the Lungs
por: Asaoka, Masato, et al.
Publicado: (2022) -
Remarkable Differences in Calcification between the Primary Tumor and Metastatic Lymph Nodes in a Patient with ALK-Positive Non-Small-Cell Lung Cancer
por: Sunata, Keeya, et al.
Publicado: (2022) -
Successful treatment of a patient with adult food allergy and severe asthma using omalizumab
por: Nishie, Miyuki, et al.
Publicado: (2021) -
Successful management of recurrent allergic bronchopulmonary aspergillosis after changing from mepolizumab to dupilumab: A case report
por: Kai, Yoshiro, et al.
Publicado: (2022) -
A case of non‐severe COVID‐19 complicated by pulmonary embolism
por: Akiyama, Yuto, et al.
Publicado: (2020)